魁省省长 called the study "big news" on social networks
Analysis of the study found that colchicine resulted in reductions in hospitalizations by 25 per cent, the need for mechanical ventilation by 50 per cent, and deaths by 44 per cent.
"This is the first hope for patients who have COVID, who are worried and who hope that they will not have complications, there were no tablets that could be taken by mouth and reduce the risks," said Tardif.
Doctor Tardif believes that prescribing the drug could help reduce congestion in hospitals quickly and reduce health-care costs here as elsewhere.
"Our study showed the effectiveness of treatment using colchicine to prevent the phenomenon of the major inflammatory storm and reduce complications related to COVID-19," said Tardif.
Colchicine could be used very quickly to treat people with COVID-19, the researcher says.
"Colchicine is old as it is, we've been treating gout with it for hundreds of years, so it's available in pharmacies, so any doctor tomorrow who reads this can definitely decide to prescribe if he wants."
On Friday evening, Premier Francois Legault called the study "big news" on social networks.
In the spring, Legault said the Colcorona study was one of the largest studies in the world to fight the virus.
The randomized, double-blind, placebo-controlled study was deployed in Canada, the United States, Europe, South America and South Africa.
"It was a double-blind study, meaning neither the patient, nor the team that ran the study including me, knew whether the patient was taking the placebo or the drug, there was just a group, independent from us, which was aware," explained Tardif.
"We are very proud of the work accomplished, it is a clinically convincing result," he said adding that he assembled a spectacular team from all over Quebec including microbiologists, intensivists, statisticians, computer scientists and epidemiologists,
中文相关报道
快讯！蒙特利尔研究人员发现对抗新冠药物-魁省新闻-蒙城华人网-蒙特利尔第一中文网!
重大利好！加拿大科学家发现新冠救命药，已经使用千年，随处可买 - 人在温哥华网 VanPeople.com
这项随机、双盲、安慰剂对照研究在加拿大、美国、欧洲、南美和南非进行。研究小组对经核酸检测证明新冠阳性的4159名患者进行了对照研究，发现口服秋水仙碱片后，可将新冠患者的住院率降低25%、呼吸机使用率降低50%、死亡率降低44%。
Tardif医生认为，秋水仙碱可以立即用于治疗新冠肺炎患者。
昨天晚上接受采访时，他说，“秋水仙碱已经有数百年历史了，我们用它来治疗痛风，可以在药店里买到，所以，明天看到这篇文章的任何医生都可以决定是不是开这个药。”
代表这个由来自魁北克省各地的微生物学家、重症病房医生、统计学家、计算机科学家和流行病学家组成的研究团队，Tardif医生最后自豪地说，“我们对完成的工作感到非常自豪，这是一个令人信服的临床结果。”
Quebec researchers say they have found an effective drug to fight COVID-19
A team of researchers from the Montreal Heart Institute believes they have found an effective weapon against COVID-19: colchicine, an oral tablet already known and used for other diseases.
montreal.ctvnews.ca
Analysis of the study found that colchicine resulted in reductions in hospitalizations by 25 per cent, the need for mechanical ventilation by 50 per cent, and deaths by 44 per cent.
"This is the first hope for patients who have COVID, who are worried and who hope that they will not have complications, there were no tablets that could be taken by mouth and reduce the risks," said Tardif.
Doctor Tardif believes that prescribing the drug could help reduce congestion in hospitals quickly and reduce health-care costs here as elsewhere.
"Our study showed the effectiveness of treatment using colchicine to prevent the phenomenon of the major inflammatory storm and reduce complications related to COVID-19," said Tardif.
Colchicine could be used very quickly to treat people with COVID-19, the researcher says.
"Colchicine is old as it is, we've been treating gout with it for hundreds of years, so it's available in pharmacies, so any doctor tomorrow who reads this can definitely decide to prescribe if he wants."
On Friday evening, Premier Francois Legault called the study "big news" on social networks.
In the spring, Legault said the Colcorona study was one of the largest studies in the world to fight the virus.
The randomized, double-blind, placebo-controlled study was deployed in Canada, the United States, Europe, South America and South Africa.
"It was a double-blind study, meaning neither the patient, nor the team that ran the study including me, knew whether the patient was taking the placebo or the drug, there was just a group, independent from us, which was aware," explained Tardif.
"We are very proud of the work accomplished, it is a clinically convincing result," he said adding that he assembled a spectacular team from all over Quebec including microbiologists, intensivists, statisticians, computer scientists and epidemiologists,
中文相关报道
快讯！蒙特利尔研究人员发现对抗新冠药物-魁省新闻-蒙城华人网-蒙特利尔第一中文网!
重大利好！加拿大科学家发现新冠救命药，已经使用千年，随处可买 - 人在温哥华网 VanPeople.com
这项随机、双盲、安慰剂对照研究在加拿大、美国、欧洲、南美和南非进行。研究小组对经核酸检测证明新冠阳性的4159名患者进行了对照研究，发现口服秋水仙碱片后，可将新冠患者的住院率降低25%、呼吸机使用率降低50%、死亡率降低44%。
Tardif医生认为，秋水仙碱可以立即用于治疗新冠肺炎患者。
昨天晚上接受采访时，他说，“秋水仙碱已经有数百年历史了，我们用它来治疗痛风，可以在药店里买到，所以，明天看到这篇文章的任何医生都可以决定是不是开这个药。”
代表这个由来自魁北克省各地的微生物学家、重症病房医生、统计学家、计算机科学家和流行病学家组成的研究团队，Tardif医生最后自豪地说，“我们对完成的工作感到非常自豪，这是一个令人信服的临床结果。”
